Igyxos: Funding, Investors & Team (Sep 2026)
Igyxos is dedicated to creating cutting-edge pharmaceuticals and medical technologies focused on human fertility. The company is actively involved in every stage of development, from identifying potential targets to obtaining intellectual property rights for promising compounds like small molecules and antibodies. Additionally, Igyxos assists in the transition of potential drug candidates through pre-clinical and clinical phases of development.
Igyxos has raised $6.7M across 1 funding round on record, the most recent an undisclosed round of $6.7M announced in Oct 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Igyxos Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Igyxos Funding Rounds
Igyxos Founders and Leadership Team
No contact details are on record for this team yet.
Igyxos Funding Compared to Other Biotechnology Startups
Igyxos' latest round of $6.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Igyxos in Biotechnology and Nouzilly
Companies Similar to Igyxos
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Igyxos Funding FAQs
What does Igyxos do?
Igyxos is dedicated to creating cutting-edge pharmaceuticals and medical technologies focused on human fertility. The company is actively involved in every stage of development, from identifying potential targets to obtaining intellectual property rights for promising compounds like small molecules and antibodies. Additionally, Igyxos assists in the transition of potential drug candidates through pre-clinical and clinical phases of development.
How much funding has Igyxos raised?
Igyxos has raised $6.7M across 1 round on record. The most recent is an undisclosed round of $6.7M announced in Oct 2025.
When did Igyxos last raise funding?
Igyxos' most recent funding round on record is an undisclosed round of $6.7M, announced in Oct 2025.
Who founded Igyxos?
FundedIQ lists Marie Christine Maurel (Founder) at Igyxos.
Where is Igyxos headquartered?
Igyxos is based in Nouzilly, Centre, France.
How many employees does Igyxos have?
Igyxos is in the 11-50 employee band.
How does Igyxos' funding compare to other Biotechnology startups?
Igyxos' latest round of $6.7M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Igyxos Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Igyxos is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.